世界中医药
文章摘要
引用本文:许博文1,2,张潇潇1,李杰1,高瑞珂1,朱广辉1,2,吴喆1.抗肿瘤中成药上市后研究要点探讨与思考[J].世界中医药,2022,(14):.  
抗肿瘤中成药上市后研究要点探讨与思考
Key Points of Post-marketing Study of Anti-tumor Chinese Patent Medicines
投稿时间:2020-11-09  
DOI:10.3969/j.issn.1673-7202.2022.14.015
中文关键词:  上市后  肿瘤  中成药  再评价  安全性  有效性  经济学  药品再评价
English Keywords:Post-marketing  Tumor  Chinese patent medicines  Re-evaluation  Safety  Efficacy  Economy  Medicine re-evaluation
基金项目:国家重点研发计划项目(2018YFC1707405);国家自然科学基金项目(81774289);北京市科技计划重大基金资助项目(D161100005116004);中国中医科学院院级自主选题(ZZ11-028)
作者单位
许博文1,2,张潇潇1,李杰1,高瑞珂1,朱广辉1,2,吴喆1 1 中国中医科学院广安门医院北京100053 2 北京中医药大学北京100029 
摘要点击次数: 320
全文下载次数: 0
中文摘要:
      抗肿瘤中成药是中医药治疗肿瘤的重要手段之一,但适应证宽泛、循证证据不足,严重制约临床推广应用,势必要不断进行上市后研究,以凸显中成药治疗的疗效与优势。基于此,现提出“以评促研、以研促评”的闭环式抗肿瘤中成药上市后研究要点。首先在评价抗肿瘤中成药在临床广泛应用后的安全性、有效性和经济性基础上,完善临床用药方案与循证评价;再基于再评价结果,挖掘并创造性地提出有价值的临床假说,进行开放式探索研究,评价与验证假说,强化抗肿瘤中成药的价值与临床定位。二者不断反馈循环,互为前提,可加速抗肿瘤中成药产品转型,致力于精准化用药和增强行业信心,进行中医药规范化、标准化和现代化研发。
English Summary:
      Anti-tumor Chinese patent medicines are one of the important means of treating tumors with Chinese medicine.However,the broad indications and insufficient evidence-based evidence seriously restrict the clinical promotion and application.It is necessary to continuously carry out the post-marketing study to highlight the efficacies and advantages of Chinese patent medicine treatment.Based on this,this paper put forward the key points of the post-marketing study of closed-loop anti-tumor Chinese patent medicines,which was “to promote research with evaluation and promote evaluation with research”.First of all,the clinical medication regimen and evidence-based evaluation should be improved based on the evaluation of the safety,efficacy,and economy of anti-tumor Chinese patent medicines after extensive clinical application.Secondly,based on the results of re-evaluation,the valuable clinical hypotheses should be excavated and creatively proposed,with the conduction of open exploration studies.The hypotheses should be evaluated and verified,and the value and clinical positioning of anti-tumor Chinese patent medicines should be strengthened.The continuous feedback cycle is the foundation to accelerate the transformation of anti-tumor Chinese patent medicines,and makes contributions to precise medication and enhancement of industrial confidence,thus realizing the normalization,standardization,and modernization of Chinese medicine research and development.
查看全文  查看/发表评论  下载PDF阅读器